SIRT5 and thyroid cancer: In this direction, our present results indicate that the use of a selective activator of sirtuin 5, called MC3138, alone or in association with a phosphate binder such as lanthanum acetate, can reduce cell viability, colony formation and mitophagy of breast and thyroid cancer cells.